As the earliest medical device in the field of intelligent medicine, there have been star products such as Da Finch operation system of Intuitive Surgery, ReWalk rehabilitation exoskeleton system in Israel. Safe, stable, and not easily disturbed by external environment, and more precise medical robots play a very important role in operation, rehabilitation treatment and medical services, and have huge market potential.
According to the consultation of Boston, the annual revenue of medical robots is 4 billion dollars, and it will reach 11 billion 400 million dollars in 2020. Among them, the most famous medical robotic company intuitive surgery has reached 2 billion 100 million dollars in 2014.
In mid May 2017, the world medical (surgery) robot innovation and Development Summit Forum, many experts said that the global medical robot industry is at the initial stage, and China, the United States and Europe are all in the “infancy”.
In addition to the technical problems facing the industry, the other is the problem of capital. The medical robot industry needs a lot of capital investment, the investment cycle is long, and it takes more than ten years for the clinical application from technology to product.
Another important part of the medical robot technology is the rehabilitation robot. In fact, 500 thousand people in the world are affected by spinal cord injury (SCI) every year, as well as patients with stroke and neurodegenerative diseases. They can benefit from rehabilitation robot technology. Power exoskeleton, rehabilitative robots and orthopedics, artificial limbs: the whole market is huge and will gradually increase market penetration.
At present, the medical robots are mainly concentrated in the North American market. The domestic market has just started, and the market penetration is less than 5%. There is huge market space and potential for development. Foreign enterprises regard the Chinese market as the key point to enhance their business. According to the forecast of GrandViewResearch, an exoskeleton robot and an auxiliary rehabilitation robot from 2012 to 2022, the market ratio will be significantly improved.
China has a population of 1 billion 300 million. Compared to the United States, the demand for medical robots is very large. Independent research and development is undoubtedly the most direct way to reduce the price of medical robots. In response to expensive equipment purchase prices and scarce purchasing indicators, some agencies have started the autonomous development of the operating robot system.
Therefore, in China, the country with the largest population and hospitals in the world is developing the world’s largest market for consumption and competition of digital medical devices. The future of medical robots is immeasurable.
But now, due to the late start, although the number of medical robot enterprises in China is increasing, the technology content is relatively low, and the products are mostly concentrated in the middle and low end medical devices.
There are not many players in the domestic medical robot, but the utilization rate and popularity rate are relatively low, but these shortcomings just indicate that our medical robot market has huge development space. As early as April 2016, the Ministry of industry, development and Reform Commission and other three ministries jointly issued the “robot industry development plan (2016 – 2020)”, proposed that by 2020, China’s service robot annual sales income of more than 30 billion yuan, realize the production and application of small batch of students in the medical rehabilitation and the elderly and the disabled.
In 2017, medical robotics became the biggest investment in the service robot industry, and in 2018 it was expected to become a new opportunity for emerging industry investors. With the progress of science and technology, we believe that the future medical robots will be more intelligent, have the ability to handle big data and deep learning, and have a good human-machine interaction experience, which is more dexterous and convenient. We will use “intelligence and intelligence” to escort the health of human beings.
About AI Digital:
AI Digital is an award winning China digital marketing agency based in Shanghai and Sydney.Working across all aspects of the marketing solutions like Baidu SEM,Wechat marketing,Weibo marketing,Soft marketing , China PPC and so on, we will ensure you have a solid marketing strategy together with perfectly delivered campaigns. AI Digital will transform your digital marketing in China to increase your lead generation, brand awareness and market engagement.
